Epilepsy webinar 1 - on demand

We are excited to announce the launch of our very first Epilepsy Academy webinar, now available to watch on demand! Simply select the 'register now' button on our website to gain access and watch at a time that is convenient for you. Please note, access to this webinar is for healthcare professionals only.

Epilepsy Academy session 1

DEE: seizures and syndromes from children to adults
Prof Simona Balestrini, associate professor of child neurology and psychiatry, Neuroscience and Medical Genetics Department, Meyer Children's Hospital - University of Florence

DEE in adults: beyond seizures
Prof Guido Rubboli, clinical professor of clinical epileptology, Institute of Clinical Medicine, University of Copenhagen

Session overview:

DEEs are burdensome conditions, individually rare but together often presenting important challenges in clinical care for people with epilepsy. Though their recognition, diagnosis, genetics and management is often well established in paediatric care, transition and adult care are often additionally challenging as the epilepsy, comorbidities and salient issues may be different in adult care and have typically been less well documented. The purpose of this webinar is to share learning about DEEs and their multifaceted management challenges in adulthood.

Session objectives:

• To appreciate that most children with DEEs survive into adulthood and are therefore important for adult and paediatric specialists to know about them and consider DEE as a diagnosis in adults.
• To understand how epilepsy phenotypes may change from paediatric to adult presentations, and the consequences of such evolution, where it occurs.
• To learn about additional features and issues in DEEs in adulthood, some of which may not manifest in childhood.

This on demand webinar has received sponsorship from Neuraxpharm. The first session in the webinar is designed and delivered by the Neurology Academy and sponsored by Neuraxpharm; the sponsor has had no input into the educational content or organisation of the session.

The second session is a promotional satellite symposium that is organised and funded by Neuraxpharm. This satellite symposium is for Healthcare Professionals only.

Neuraxpharm satellite symposium session 2:
Transition care and prolonged convulsive seizure

Session summary:

• What is the definition and the risk factors/etiologies of prolonged convulsive seizures? What are the main differences between children vs adult epilepsy patients?
• What are the main current barriers/difficulties in epilepsy patients suffering from prolonged seizures when they become adults? What are the main considerations to ensure the continuity of care?
• How important is to provide rescue medication to these patients in the community setting and what is the current management during transition and in adults and recommendations?
• How the family or other caregivers’ epilepsy patients should be empowered about transition care and prolonged convulsive seizures management?
  

Session objectives:

• How can a successful transition mitigate the challenges of managing prolonged seizures in adults?
• What are the specific challenges of managing prolonged seizures in children and adults and what recommendations can be given to HCPs to overcome them?

This event is free to attend as a result of sponsorship from our sponsors. The current event sponsors are listed on this page. In the interest of Neurology Academy and our sponsors’ legitimate business interests, we make available your name, job title and workplace to our sponsors. It allows us to attract the most appropriate sponsors, delegates and speakers for the events and to facilitate potential collaboration and communication between you and the sponsors; and allows us to offer other relevant events and services to the healthcare and life science industries. You can ask us not to share your name, job title and workplace by emailing info@neurologyacademy.org. We respect the privacy of every person for whom we have personal data. The group privacy and cookies policy can be viewed here.